Cambridge, Massachusetts-based Disc Medicine, a hematology company, has raised $50 million in Series A financing. Novo Holdings A/S led the round with participation from Access Biotechnology and Atlas Venture.
Source: Press Release
Disc Medicine scores $50 mln Series A
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.